Results 21-40 of 8,500 for speaker:John Brady
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: -----irrespective of whether they had something to declare or-----
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: They filled it in. There was a process for all consultants to fill it in.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: It is mandatory.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: In the context of Beaumont, a figure of 81% was provided in respect of the public-only contract. How many consultants in total are engaged by Beaumont?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: But there is no process, similar to that in Drogheda, to ensure that the responsibility of the employer, which, in this case, is Beaumont, is complied with. There is no cross-referencing or anything like that to ensure that this is the case.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: I think the management certainly does. There is work that needs to be done in that regard. I will deal with the issue of insourcing. Mr. Hanlon gave two figures for Beaumont for 2024, namely €11 million and €8.7 million. Will he explain why the figures are different?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: In 2024, it was €8.7 million.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Can Mr. Hanlon break that down further with regard to insourcing for third parties, particularly as there is a difference?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Okay.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: The €3.1 million was for insourcing. Would I be correct in saying that was to cover, I suppose, consultants who were on public contracts but it also involves engaging with third parties and utilising their work outside of and bringing them into Beaumont?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Will Ms Brady give us a breakdown of the figures relating to the insourcing and the engagement with third parties for 2024?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: I will park my questions for now and will return to them if we get a second round.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: To return to the issue of in-sourcing, I refer to the report by the Minister that revealed that in the 27 months to the end of March 2025, close to €100 million was paid out engaging external companies that use HSE facilities and equipment after normal hours. The report revealed that 83 serving or former health staff are acting as directors in 148 companies providing what are known as...
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Is that how Ms Coyle would see it in operation in Beaumont Hospital?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: We might get those figures. As has been stated here, there are some consultants - we are not sure about the figure or percentage - who have not filled out the statutory SIPO declarations. Does Ms Coyle think there is potential for conflict of interest? Do we know of any consultants in Beaumont who has been a director of any of those companies that are providing in-sourcing through third...
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Potential? Would Mr. Sweeney be concerned that the potential has not been explored if he thinks there is potential for a conflict of interest?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: I am talking about Beaumont rather than national level. Mr. Sweeney said there is the potential for a conflict of interest. Is he concerned that there may be a conflict of interest involving a consultant? He does not know whether there is or there is not. I find it extraordinary that piece of due diligence has not been explored or investigated, the fact we do not know whether consultants...
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Can I ask a direct question? Are any consultants who currently work or have worked within Beaumont over the past number of years involved in third party providers of in-sourcing?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: I am talking about Beaumont. Mr. Sweeney said there is potential for concern. What due diligence-----
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) John Brady: Potential for a conflict of interest - I think that needs to be looked at if there is potential for a conflict of interest. Mr. Sweeney said consultants. Is it consultants who are or have worked there, or both?